Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
3.350
-0.020 (-0.59%)
At close: Sep 18, 2026, 4:00 PM EDT
3.335
-0.015 (-0.45%)
After-hours: Sep 18, 2026, 7:49 PM EDT
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $1.23 billion as of September 18, 2026. Its market cap has increased by 24.31% in one year.
Market Cap
1.23B
Enterprise Value
470.96M
1-Year Change
24.31%
Ranking
Category
Stock Price
$3.35
ChartMarket Cap Chart
Since February 27, 2018, Cronos Group's market cap has increased from $1.14B to $1.23B, an increase of 7.91%. That is a compound annual growth rate of 0.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.23B | 22.56% |
| Dec 31, 2025 | 1.01B | 30.41% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Perrigo Company | 1.88B |
| ANI Pharmaceuticals | 1.63B |
| Eton Pharmaceuticals | 1.59B |
| Xeris Biopharma Holdings | 1.50B |
| Phibro Animal Health | 1.40B |
| Harrow | 1.24B |
| Amphastar Pharmaceuticals | 1.00B |
| Pacira BioSciences | 984.19M |